NCT01378585View on ClinicalTrials.gov

Safety and Efficacy of DLBS1033 in Healthy Subjects

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Healthy
Interventions
DRUG

DLBS1033

3 x 490 mg DLBS1033 daily

DRUG

Placebo

3 x 1 tablet daily

Trial Locations (1)

12430

PT Equilab International, Jakarta

Sponsors

Lead Sponsor

Dexa Medica Group
All Listed Sponsors
lead

Dexa Medica Group

INDUSTRY

NCT01378585 - Safety and Efficacy of DLBS1033 in Healthy Subjects | Biotech Hunter | Biotech Hunter